CytoPherx's Series C Round

CytoPherx raised a round of funding on January 04, 2012.

CytoPherx, formerly Nephrion, is a clinical stage medical device company addressing inflammation based diseases and conditions with a selective cytopheresis-based inflammation modulating system.…

Articles about CytoPherx's Series C Round: